Clinical Trial Update: Double Blind Placebo Controlled Study on the Effect of Extracorporal Shock Wave Therapy on Erectile Dysfunction in PDE5i Responders [Phase 3]

View source ↗

Summary

Phase 3 double-blind placebo-controlled trial evaluating extracorporeal shock wave therapy for erectile dysfunction in men who respond to PDE5 inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Extracorporeal Shock Wave Therapy

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Erectile Dysfunction | Phase 3 | Status: UNKNOWN